Skip to main content

A Payer Perspective

In-Depth Treatment Profile, A Payer Perspective, FDA Approvals, Bispecific Antibodies

Bispecific Antibody Columvi Offering Option in Diffuse Large B-cell Lymphoma Treatment

Rohan Vashi, PharmD, MSc

Rohan Vashi, PharmD, MSc

A Payer Perspective

Challenges Facing the US Healthcare System in 2023 and Beyond: A Payer Perspective

Gary M. Owens, MD

Gary M. Owens, MD

Practice Management, Business, A Payer Perspective

The Business Case for Payer Support of a Community-Based Health Information Exchange: A Humana Pilot Evaluating Its Effectiveness in Cost Control for Plan Members Seeking Emergency Department Care

Albert Tzeel, MD, MHSA, CPE, FAAPL, Victor Lawnicki, PhD, Kim R. Pemble, MS

Stakeholder Perspective

Health as a Sustainability Strategy: We Need a Healthcare System Focused on Keeping People Healthy Rather than Adding Layers to the Already Too Long, Fragmented Supply Chain

by Alberto M. Colombi, MD, MPH

A Payer Perspective

Drug Delivery Systems for Administration of Inhaled Therapies in Patients with Chronic Obstructive Pulmonary Disease

Results 1 - 4 of 4